HPP Stock Overview
Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America.
Health and Plant Protein Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.075|
|52 Week High||AU$0.23|
|52 Week Low||AU$0.07|
|1 Month Change||-6.25%|
|3 Month Change||7.14%|
|1 Year Change||-59.46%|
|3 Year Change||-59.46%|
|5 Year Change||-72.22%|
|Change since IPO||-98.51%|
Recent News & Updates
Is Health and Plant Protein Group (ASX:HPP) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Here's Why Health and Plant Protein Group (ASX:HPP) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
|HPP||AU Food||AU Market|
Return vs Industry: HPP underperformed the Australian Food industry which returned -17% over the past year.
Return vs Market: HPP underperformed the Australian Market which returned -9.7% over the past year.
|HPP Average Weekly Movement||n/a|
|Food Industry Average Movement||6.3%|
|Market Average Movement||9.4%|
|10% most volatile stocks in AU Market||16.5%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: Insufficient data to determine HPP's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine HPP's volatility change over the past year.
About the Company
Health and Plant Protein Group Limited engages in the processing, production, and marketing of macadamia products to wholesale and retail customers in North America. It offers its products under the Royal Hawaiian Orchards and MacFarms brands. The company was formerly known as Buderim Group Limited and changed its name to Health and Plant Protein Group Limited in December 2020.
Health and Plant Protein Group Fundamentals Summary
|HPP fundamental statistics|
Is HPP overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|HPP income statement (TTM)|
|Cost of Revenue||AU$36.19m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.0054|
|Net Profit Margin||1.57%|
How did HPP perform over the long term?See historical performance and comparison
Is HPP undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HPP?
Other financial metrics that can be useful for relative valuation.
|What is HPP's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does HPP's PE Ratio compare to its peers?
|HPP PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
YOW Yowie Group
FFI FFI Holdings
CSS Clean Seas Seafood
HPP Health and Plant Protein Group
Price-To-Earnings vs Peers: HPP is good value based on its Price-To-Earnings Ratio (13.9x) compared to the peer average (16.3x).
Price to Earnings Ratio vs Industry
How does HPP's PE Ratio compare vs other companies in the Oceanian Food Industry?
Price-To-Earnings vs Industry: HPP is good value based on its Price-To-Earnings Ratio (13.9x) compared to the Oceanic Food industry average (16.5x)
Price to Earnings Ratio vs Fair Ratio
What is HPP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||13.9x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HPP's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of HPP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HPP (A$0.08) is trading below our estimate of fair value (A$0.09)
Significantly Below Fair Value: HPP is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Health and Plant Protein Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Health and Plant Protein Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine whether Health and Plant Protein Group is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Health and Plant Protein Group competitive advantages and company strategy can generally be found in its financial reports archived here.
How has Health and Plant Protein Group performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HPP has a large one-off gain of A$8.4M impacting its June 30 2022 financial results.
Growing Profit Margin: HPP became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: HPP has become profitable over the past 5 years, growing earnings by 14.2% per year.
Accelerating Growth: HPP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HPP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Food industry (9%).
Return on Equity
High ROE: HPP's Return on Equity (2.7%) is considered low.
Discover strong past performing companies
How is Health and Plant Protein Group's financial position?
Financial Health Score1/6
Financial Health Score 1/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: HPP's short term assets (A$23.5M) exceed its short term liabilities (A$6.7M).
Long Term Liabilities: HPP's short term assets (A$23.5M) do not cover its long term liabilities (A$24.4M).
Debt to Equity History and Analysis
Debt Level: HPP's net debt to equity ratio (65.7%) is considered high.
Reducing Debt: HPP's debt to equity ratio has increased from 33% to 79.6% over the past 5 years.
Debt Coverage: HPP's debt is not well covered by operating cash flow (7%).
Interest Coverage: Insufficient data to determine if HPP's interest payments on its debt are well covered by EBIT.
Discover healthy companies
What is Health and Plant Protein Group current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
|Health and Plant Protein Group Dividend Yield vs Market|
|Company (Health and Plant Protein Group)||0%|
|Market Bottom 25% (AU)||2.8%|
|Market Top 25% (AU)||7.2%|
|Industry Average (Food)||3.4%|
|Analyst forecast in 3 Years (Health and Plant Protein Group)||n/a|
Notable Dividend: Unable to evaluate HPP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate HPP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if HPP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if HPP's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: HPP is not paying a notable dividend for the Australian market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as HPP has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Health and Plant Protein Group has no CEO, or we have no data on them.
Experienced Management: HPP's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Experienced Board: HPP's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Health and Plant Protein Group Limited's employee growth, exchange listings and data sources
- Name: Health and Plant Protein Group Limited
- Ticker: HPP
- Exchange: ASX
- Founded: 1941
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Implied Market Cap: AU$9.212m
- Shares outstanding: 122.82m
- Website: https://www.hppgroup.com
Number of Employees
- Health and Plant Protein Group Limited
- 159 Coronation Drive
- Level 3
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|HPP||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|HPP||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jan 1992|
|0EG0||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jan 1992|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/30 00:00|
|End of Day Share Price||2022/09/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.